X. . Zhang, “Laboratory Biomarkers and Immunological Modulation of Sintilimab in Gastric Cancer: A Meta-Analysis Focused on Tumor Markers and T-Cell Subsets: Sintilimab for Gastric Cancer: Efficacy, Markers, and Safety”, J Med Biochem, vol. 44, no. 6, pp. 1171–1182, Jul. 2025, doi: 10.5937/jomb0-59513.